Rank | Gene Set | Z-score |
---|---|---|
1 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 7.88435196 |
2 | muscle filament sliding (GO:0030049) | 7.72728016 |
3 | actin-myosin filament sliding (GO:0033275) | 7.72728016 |
4 | actin-mediated cell contraction (GO:0070252) | 6.27233920 |
5 | skeletal muscle contraction (GO:0003009) | 6.02473488 |
6 | regulation of skeletal muscle contraction (GO:0014819) | 6.01758028 |
7 | regulation of relaxation of muscle (GO:1901077) | 5.35495130 |
8 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 5.34837301 |
9 | striated muscle contraction (GO:0006941) | 5.11871226 |
10 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 5.09527727 |
11 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.06682419 |
12 | myofibril assembly (GO:0030239) | 4.98808074 |
13 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.98345557 |
14 | synaptic vesicle maturation (GO:0016188) | 4.92706892 |
15 | creatine metabolic process (GO:0006600) | 4.88632634 |
16 | synaptic vesicle exocytosis (GO:0016079) | 4.83043253 |
17 | actin filament-based movement (GO:0030048) | 4.63701245 |
18 | neuron cell-cell adhesion (GO:0007158) | 4.63623218 |
19 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.53053354 |
20 | regulation of cell communication by electrical coupling (GO:0010649) | 4.43293340 |
21 | glutamate secretion (GO:0014047) | 4.40787963 |
22 | sarcomere organization (GO:0045214) | 4.40356596 |
23 | neuronal action potential propagation (GO:0019227) | 4.39315665 |
24 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 4.39144968 |
25 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 4.29798347 |
26 | protein localization to synapse (GO:0035418) | 4.26505961 |
27 | response to muscle activity (GO:0014850) | 4.25267783 |
28 | cardiac muscle contraction (GO:0060048) | 4.21676775 |
29 | vocalization behavior (GO:0071625) | 4.16420790 |
30 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.09239103 |
31 | cardiac myofibril assembly (GO:0055003) | 4.08406971 |
32 | response to inactivity (GO:0014854) | 4.05771755 |
33 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.04992477 |
34 | skeletal muscle fiber development (GO:0048741) | 4.03175989 |
35 | regulation of actin filament-based movement (GO:1903115) | 4.01028870 |
36 | regulation of synaptic vesicle transport (GO:1902803) | 3.98010853 |
37 | muscle contraction (GO:0006936) | 3.88678885 |
38 | neurotransmitter secretion (GO:0007269) | 3.85034741 |
39 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.83353989 |
40 | central nervous system myelination (GO:0022010) | 3.81306345 |
41 | axon ensheathment in central nervous system (GO:0032291) | 3.81306345 |
42 | locomotory exploration behavior (GO:0035641) | 3.74553105 |
43 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.70544441 |
44 | regulation of membrane repolarization (GO:0060306) | 3.69815653 |
45 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.68865336 |
46 | myotube cell development (GO:0014904) | 3.65264131 |
47 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.65127777 |
48 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.57767836 |
49 | plasma membrane repair (GO:0001778) | 3.56625498 |
50 | positive regulation of synapse maturation (GO:0090129) | 3.55790444 |
51 | cardiac muscle hypertrophy (GO:0003300) | 3.53510327 |
52 | muscle fiber development (GO:0048747) | 3.53303825 |
53 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.52460478 |
54 | neuromuscular process controlling posture (GO:0050884) | 3.52320692 |
55 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.49297678 |
56 | muscle system process (GO:0003012) | 3.48518176 |
57 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.47673989 |
58 | neuron-neuron synaptic transmission (GO:0007270) | 3.47651219 |
59 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.47018160 |
60 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.47018160 |
61 | layer formation in cerebral cortex (GO:0021819) | 3.45190882 |
62 | neurotransmitter transport (GO:0006836) | 3.42655300 |
63 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.42317560 |
64 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.42267662 |
65 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.42267662 |
66 | glycine transport (GO:0015816) | 3.40554905 |
67 | synaptic transmission, glutamatergic (GO:0035249) | 3.39740218 |
68 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.38993015 |
69 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.37855499 |
70 | proline transport (GO:0015824) | 3.36494705 |
71 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.36212786 |
72 | striated muscle hypertrophy (GO:0014897) | 3.35865017 |
73 | negative regulation of microtubule polymerization (GO:0031115) | 3.35433503 |
74 | neuron recognition (GO:0008038) | 3.35392776 |
75 | actomyosin structure organization (GO:0031032) | 3.31521657 |
76 | cell migration in hindbrain (GO:0021535) | 3.31091832 |
77 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.28540172 |
78 | regulation of synapse structural plasticity (GO:0051823) | 3.28284794 |
79 | glycogen catabolic process (GO:0005980) | 3.26884451 |
80 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.26205983 |
81 | gamma-aminobutyric acid transport (GO:0015812) | 3.24485489 |
82 | transmission of nerve impulse (GO:0019226) | 3.23170933 |
83 | prepulse inhibition (GO:0060134) | 3.22941576 |
84 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.20410867 |
85 | exploration behavior (GO:0035640) | 3.19632410 |
86 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.19550861 |
87 | regulation of vesicle fusion (GO:0031338) | 3.19545980 |
88 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.19343599 |
89 | presynaptic membrane assembly (GO:0097105) | 3.18609055 |
90 | presynaptic membrane organization (GO:0097090) | 3.18260249 |
91 | mating behavior (GO:0007617) | 3.17734362 |
92 | glutamate receptor signaling pathway (GO:0007215) | 3.16517913 |
93 | adult walking behavior (GO:0007628) | 3.15566339 |
94 | neuronal action potential (GO:0019228) | 3.13675453 |
95 | membrane depolarization during action potential (GO:0086010) | 3.12301756 |
96 | detection of calcium ion (GO:0005513) | 3.11958556 |
97 | regulation of synapse maturation (GO:0090128) | 3.11397188 |
98 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.11030337 |
99 | regulation of neurotransmitter secretion (GO:0046928) | 3.10781999 |
100 | regulation of striated muscle contraction (GO:0006942) | 3.09831123 |
101 | regulation of neurotransmitter levels (GO:0001505) | 3.09660236 |
102 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.09533212 |
103 | cellular potassium ion homeostasis (GO:0030007) | 3.08815639 |
104 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.07937013 |
105 | skeletal muscle adaptation (GO:0043501) | 3.07296102 |
106 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.06543791 |
107 | potassium ion import (GO:0010107) | 3.05622708 |
108 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 3.04316387 |
109 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 3.04316387 |
110 | dendritic spine morphogenesis (GO:0060997) | 3.02877295 |
111 | glucan catabolic process (GO:0009251) | 3.02851948 |
112 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.02765094 |
113 | neuromuscular synaptic transmission (GO:0007274) | 3.01436294 |
114 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.00651881 |
115 | membrane hyperpolarization (GO:0060081) | 3.00636051 |
116 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 3.00582398 |
117 | striated muscle adaptation (GO:0014888) | 3.00239630 |
118 | neuronal ion channel clustering (GO:0045161) | 3.00122729 |
119 | regulation of neurotransmitter transport (GO:0051588) | 2.99579597 |
120 | establishment of mitochondrion localization (GO:0051654) | 2.99433119 |
121 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.98598044 |
122 | activation of protein kinase A activity (GO:0034199) | 2.98522215 |
123 | behavioral response to cocaine (GO:0048148) | 2.96205966 |
124 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.96167345 |
125 | regulation of postsynaptic membrane potential (GO:0060078) | 2.95073981 |
126 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.95033141 |
127 | long-term memory (GO:0007616) | 2.94051819 |
128 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.92694048 |
129 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.91338952 |
130 | cardiac muscle adaptation (GO:0014887) | 2.91078046 |
131 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 2.91078046 |
132 | muscle hypertrophy in response to stress (GO:0003299) | 2.91078046 |
133 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.90969911 |
134 | muscle hypertrophy (GO:0014896) | 2.90883769 |
135 | axonal fasciculation (GO:0007413) | 2.89039045 |
136 | regulation of sodium ion transmembrane transporter activity (GO:2000649) | 2.88322103 |
137 | membrane depolarization (GO:0051899) | 2.87557241 |
138 | regulation of synaptic transmission, GABAergic (GO:0032228) | 2.87332082 |
139 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.86737801 |
140 | positive regulation of membrane potential (GO:0045838) | 2.86447386 |
141 | synapse assembly (GO:0007416) | 2.85860725 |
142 | regulation of sodium ion transmembrane transport (GO:1902305) | 2.85813799 |
143 | adult heart development (GO:0007512) | 2.85322475 |
144 | skeletal muscle tissue development (GO:0007519) | 2.83764437 |
145 | synaptic vesicle endocytosis (GO:0048488) | 2.83681917 |
146 | regulation of dopamine metabolic process (GO:0042053) | 2.83476541 |
147 | regulation of catecholamine metabolic process (GO:0042069) | 2.83476541 |
148 | regulation of glutamate secretion (GO:0014048) | 2.82171446 |
149 | calcium ion-dependent exocytosis (GO:0017156) | 2.81155982 |
150 | synaptic transmission, dopaminergic (GO:0001963) | 2.80531469 |
151 | response to auditory stimulus (GO:0010996) | 2.79900808 |
152 | postsynaptic membrane organization (GO:0001941) | 2.79615206 |
153 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 2.77931866 |
154 | cellular polysaccharide catabolic process (GO:0044247) | 2.77711278 |
155 | vesicle transport along microtubule (GO:0047496) | 2.76904753 |
156 | positive regulation of sodium ion transport (GO:0010765) | 2.76386375 |
157 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.75987310 |
158 | positive regulation of cation channel activity (GO:2001259) | 2.75576125 |
159 | glucan biosynthetic process (GO:0009250) | 2.75534468 |
160 | glycogen biosynthetic process (GO:0005978) | 2.75534468 |
161 | dendrite morphogenesis (GO:0048813) | 2.75033348 |
162 | muscle cell cellular homeostasis (GO:0046716) | 2.74717705 |
163 | striatum development (GO:0021756) | 2.73969304 |
164 | dopamine receptor signaling pathway (GO:0007212) | 2.73855839 |
165 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 2.73709972 |
166 | detection of temperature stimulus (GO:0016048) | 2.73262022 |
167 | auditory behavior (GO:0031223) | 2.73091783 |
168 | NADH metabolic process (GO:0006734) | 2.70758158 |
169 | potassium ion homeostasis (GO:0055075) | 2.68586036 |
170 | relaxation of muscle (GO:0090075) | 2.66813547 |
171 | behavioral response to nicotine (GO:0035095) | 2.66433015 |
172 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.66219434 |
173 | regulation of potassium ion transmembrane transporter activity (GO:1901016) | 2.65262463 |
174 | negative regulation of potassium ion transport (GO:0043267) | 2.64094364 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.29572230 |
2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.29881106 |
3 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.10850867 |
4 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.94378908 |
5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.89160062 |
6 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.72545862 |
7 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.63703165 |
8 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.59353639 |
9 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.59353639 |
10 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.57922781 |
11 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.55206576 |
12 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.50664337 |
13 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.49931100 |
14 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.47182041 |
15 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.43991679 |
16 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.40656966 |
17 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.33812138 |
18 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.31490657 |
19 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.31198194 |
20 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.24857399 |
21 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.24202918 |
22 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.22260016 |
23 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.10598495 |
24 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.04776947 |
25 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.03048002 |
26 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.02631812 |
27 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.80781869 |
28 | * CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.78165992 |
29 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.77380999 |
30 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.72994829 |
31 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.67796547 |
32 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.66243176 |
33 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.62683353 |
34 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.60321083 |
35 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.59006505 |
36 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.52612893 |
37 | * ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.52067490 |
38 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.50301253 |
39 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.45352447 |
40 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.44107239 |
41 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.43764235 |
42 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.42411558 |
43 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.41658138 |
44 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.40718374 |
45 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.40654795 |
46 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.40624904 |
47 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.40586088 |
48 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.38359027 |
49 | P300_19829295_ChIP-Seq_ESCs_Human | 1.38078042 |
50 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.37410700 |
51 | VDR_22108803_ChIP-Seq_LS180_Human | 1.36769639 |
52 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.35689844 |
53 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.33303190 |
54 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.28986682 |
55 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.26559923 |
56 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.25351556 |
57 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.24418242 |
58 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.24181257 |
59 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.23165331 |
60 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.22934548 |
61 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.22024248 |
62 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.18640428 |
63 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.18624295 |
64 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.18169540 |
65 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.13760444 |
66 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.13749641 |
67 | AR_25329375_ChIP-Seq_VCAP_Human | 1.12453159 |
68 | STAT3_23295773_ChIP-Seq_U87_Human | 1.11647194 |
69 | * P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.11295225 |
70 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.10609710 |
71 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.09927983 |
72 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.08823674 |
73 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.05234630 |
74 | * TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.05077378 |
75 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.04892861 |
76 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.04716774 |
77 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.04164092 |
78 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.04133430 |
79 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.03074229 |
80 | AR_19668381_ChIP-Seq_PC3_Human | 1.01975267 |
81 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.98937823 |
82 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.97525360 |
83 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.97291811 |
84 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.97067239 |
85 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.95852773 |
86 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.95792955 |
87 | * TCF4_23295773_ChIP-Seq_U87_Human | 0.94579157 |
88 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.94232583 |
89 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.93634387 |
90 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.92672451 |
91 | * MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.91676709 |
92 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.91395710 |
93 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.90771167 |
94 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.90605197 |
95 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.88104537 |
96 | JUN_21703547_ChIP-Seq_K562_Human | 0.87374757 |
97 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.87137133 |
98 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.87092620 |
99 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.86782315 |
100 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.86782315 |
101 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.86630338 |
102 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.86627015 |
103 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.86063625 |
104 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.85695597 |
105 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.85543817 |
106 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.85135021 |
107 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.82906734 |
108 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.82487008 |
109 | KDM2B_26808549_Chip-Seq_K562_Human | 0.81918899 |
110 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.81176032 |
111 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.81176032 |
112 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.79749395 |
113 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.79481117 |
114 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.78666280 |
115 | * LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.78316132 |
116 | * STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.78071640 |
117 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.77931157 |
118 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.77028476 |
119 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.76360210 |
120 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.76072540 |
121 | * OCT4_20526341_ChIP-Seq_ESCs_Human | 0.75606665 |
122 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.75382999 |
123 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.75167442 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003646_muscle_fatigue | 5.08267697 |
2 | MP0003880_abnormal_central_pattern | 4.49821145 |
3 | MP0004859_abnormal_synaptic_plasticity | 4.47283776 |
4 | MP0004270_analgesia | 3.93216159 |
5 | MP0001968_abnormal_touch/_nociception | 3.70760250 |
6 | MP0003635_abnormal_synaptic_transmissio | 3.37563938 |
7 | MP0002734_abnormal_mechanical_nocicepti | 3.06177848 |
8 | MP0002735_abnormal_chemical_nociception | 2.98296220 |
9 | MP0006276_abnormal_autonomic_nervous | 2.97255114 |
10 | MP0009745_abnormal_behavioral_response | 2.94954378 |
11 | MP0002736_abnormal_nociception_after | 2.88879745 |
12 | MP0005423_abnormal_somatic_nervous | 2.84046925 |
13 | MP0002064_seizures | 2.83942658 |
14 | MP0002272_abnormal_nervous_system | 2.78775675 |
15 | MP0009046_muscle_twitch | 2.73315668 |
16 | MP0002106_abnormal_muscle_physiology | 2.70378154 |
17 | MP0002063_abnormal_learning/memory/cond | 2.67612604 |
18 | MP0002822_catalepsy | 2.65595153 |
19 | MP0002733_abnormal_thermal_nociception | 2.61321286 |
20 | MP0001970_abnormal_pain_threshold | 2.46066304 |
21 | MP0002572_abnormal_emotion/affect_behav | 2.44666284 |
22 | MP0004130_abnormal_muscle_cell | 2.35723452 |
23 | MP0004084_abnormal_cardiac_muscle | 2.32930649 |
24 | MP0001486_abnormal_startle_reflex | 2.32760193 |
25 | MP0002332_abnormal_exercise_endurance | 2.29993584 |
26 | MP0000759_abnormal_skeletal_muscle | 2.29935179 |
27 | MP0004087_abnormal_muscle_fiber | 2.28710596 |
28 | MP0005369_muscle_phenotype | 2.25245288 |
29 | MP0001529_abnormal_vocalization | 2.12240242 |
30 | MP0005620_abnormal_muscle_contractility | 2.11291322 |
31 | MP0002067_abnormal_sensory_capabilities | 2.05449165 |
32 | MP0001440_abnormal_grooming_behavior | 2.04465219 |
33 | MP0002269_muscular_atrophy | 2.02003171 |
34 | MP0001905_abnormal_dopamine_level | 1.96687614 |
35 | MP0000750_abnormal_muscle_regeneration | 1.89379789 |
36 | MP0002184_abnormal_innervation | 1.89310200 |
37 | MP0004215_abnormal_myocardial_fiber | 1.89012757 |
38 | MP0004858_abnormal_nervous_system | 1.87052805 |
39 | MP0001501_abnormal_sleep_pattern | 1.85216717 |
40 | MP0003122_maternal_imprinting | 1.81625223 |
41 | MP0000778_abnormal_nervous_system | 1.80708188 |
42 | MP0005386_behavior/neurological_phenoty | 1.79468391 |
43 | MP0004924_abnormal_behavior | 1.79468391 |
44 | MP0004142_abnormal_muscle_tone | 1.75072919 |
45 | MP0001986_abnormal_taste_sensitivity | 1.67863276 |
46 | MP0004233_abnormal_muscle_weight | 1.66102074 |
47 | MP0003329_amyloid_beta_deposits | 1.65771928 |
48 | MP0005330_cardiomyopathy | 1.62566977 |
49 | MP0008569_lethality_at_weaning | 1.61282500 |
50 | MP0004811_abnormal_neuron_physiology | 1.59330550 |
51 | MP0000955_abnormal_spinal_cord | 1.59161557 |
52 | MP0002557_abnormal_social/conspecific_i | 1.58635295 |
53 | MP0002972_abnormal_cardiac_muscle | 1.58264507 |
54 | MP0001984_abnormal_olfaction | 1.58158853 |
55 | MP0005646_abnormal_pituitary_gland | 1.55174194 |
56 | MP0000920_abnormal_myelination | 1.53301123 |
57 | MP0005645_abnormal_hypothalamus_physiol | 1.52782049 |
58 | MP0002882_abnormal_neuron_morphology | 1.51814007 |
59 | MP0005451_abnormal_body_composition | 1.48528150 |
60 | MP0004145_abnormal_muscle_electrophysio | 1.43181545 |
61 | MP0001502_abnormal_circadian_rhythm | 1.41663488 |
62 | MP0006036_abnormal_mitochondrial_physio | 1.41658089 |
63 | MP0002066_abnormal_motor_capabilities/c | 1.40979014 |
64 | MP0002909_abnormal_adrenal_gland | 1.38992426 |
65 | MP0004484_altered_response_of | 1.35033196 |
66 | MP0002229_neurodegeneration | 1.32637091 |
67 | MP0005551_abnormal_eye_electrophysiolog | 1.31282815 |
68 | MP0004885_abnormal_endolymph | 1.31159849 |
69 | MP0000751_myopathy | 1.30585939 |
70 | MP0004742_abnormal_vestibular_system | 1.28290998 |
71 | MP0003123_paternal_imprinting | 1.26353573 |
72 | MP0003633_abnormal_nervous_system | 1.24574286 |
73 | MP0002638_abnormal_pupillary_reflex | 1.20212579 |
74 | MP0003634_abnormal_glial_cell | 1.18518465 |
75 | MP0010386_abnormal_urinary_bladder | 1.15773892 |
76 | MP0009780_abnormal_chondrocyte_physiolo | 1.11808312 |
77 | MP0005266_abnormal_metabolism | 1.09762542 |
78 | MP0003631_nervous_system_phenotype | 1.07086944 |
79 | MP0003879_abnormal_hair_cell | 1.06924192 |
80 | MP0004510_myositis | 1.05442233 |
81 | MP0002108_abnormal_muscle_morphology | 1.04560081 |
82 | MP0008775_abnormal_heart_ventricle | 1.04173169 |
83 | MP0002752_abnormal_somatic_nervous | 1.02106316 |
84 | MP0002751_abnormal_autonomic_nervous | 1.01125041 |
85 | MP0000733_abnormal_muscle_development | 0.98660839 |
86 | MP0003121_genomic_imprinting | 0.98513140 |
87 | MP0008872_abnormal_physiological_respon | 0.97773095 |
88 | MP0005385_cardiovascular_system_phenoty | 0.97490849 |
89 | MP0001544_abnormal_cardiovascular_syste | 0.97490849 |
90 | MP0001188_hyperpigmentation | 0.95994904 |
91 | MP0002152_abnormal_brain_morphology | 0.95312443 |
92 | MP0000013_abnormal_adipose_tissue | 0.92617384 |
93 | MP0006072_abnormal_retinal_apoptosis | 0.91839999 |
94 | MP0003787_abnormal_imprinting | 0.90920248 |
95 | MP0003690_abnormal_glial_cell | 0.89842126 |
96 | MP0000747_muscle_weakness | 0.89837638 |
97 | MP0002069_abnormal_eating/drinking_beha | 0.88781879 |
98 | MP0006138_congestive_heart_failure | 0.87778998 |
99 | MP0002127_abnormal_cardiovascular_syste | 0.87553767 |
100 | MP0010630_abnormal_cardiac_muscle | 0.87252922 |
101 | MP0005499_abnormal_olfactory_system | 0.85747890 |
102 | MP0005394_taste/olfaction_phenotype | 0.85747890 |
103 | MP0005535_abnormal_body_temperature | 0.84582919 |
104 | MP0004147_increased_porphyrin_level | 0.83049339 |
105 | MP0001664_abnormal_digestion | 0.81878985 |
106 | MP0001963_abnormal_hearing_physiology | 0.81844746 |
107 | MP0004085_abnormal_heartbeat | 0.81343341 |
108 | MP0002971_abnormal_brown_adipose | 0.80570407 |
109 | MP0008260_abnormal_autophagy | 0.80329824 |
110 | MP0005409_darkened_coat_color | 0.80116766 |
111 | MP0000631_abnormal_neuroendocrine_gland | 0.78670787 |
112 | MP0005253_abnormal_eye_physiology | 0.76385839 |
113 | MP0001299_abnormal_eye_distance/ | 0.75528867 |
114 | MP0001485_abnormal_pinna_reflex | 0.74100107 |
115 | MP0008874_decreased_physiological_sensi | 0.73849660 |
116 | MP0002837_dystrophic_cardiac_calcinosis | 0.73033688 |
117 | MP0003632_abnormal_nervous_system | 0.72667915 |
118 | MP0005167_abnormal_blood-brain_barrier | 0.69344424 |
119 | MP0002078_abnormal_glucose_homeostasis | 0.68324348 |
120 | MP0008877_abnormal_DNA_methylation | 0.65312103 |
121 | MP0004043_abnormal_pH_regulation | 0.64781775 |
122 | MP0005171_absent_coat_pigmentation | 0.64502746 |
123 | MP0000003_abnormal_adipose_tissue | 0.62111874 |
124 | MP0000604_amyloidosis | 0.61949859 |
125 | MP0002090_abnormal_vision | 0.60933805 |
126 | MP0003137_abnormal_impulse_conducting | 0.59796529 |
127 | MP0001943_abnormal_respiration | 0.59621407 |
128 | MP0001177_atelectasis | 0.57950412 |
129 | MP0005083_abnormal_biliary_tract | 0.57462543 |
130 | MP0004036_abnormal_muscle_relaxation | 0.56043648 |
131 | MP0005410_abnormal_fertilization | 0.55135108 |
132 | MP0005379_endocrine/exocrine_gland_phen | 0.53228635 |
133 | MP0003283_abnormal_digestive_organ | 0.50297928 |
134 | MP0002876_abnormal_thyroid_physiology | 0.49444371 |
135 | MP0000749_muscle_degeneration | 0.49030145 |
136 | MP0003956_abnormal_body_size | 0.48721652 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Muscle fiber inclusion bodies (HP:0100299) | 9.24520444 |
2 | Nemaline bodies (HP:0003798) | 9.19801173 |
3 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 8.90423960 |
4 | Type 1 muscle fiber predominance (HP:0003803) | 6.95778832 |
5 | Exercise-induced myalgia (HP:0003738) | 6.94958096 |
6 | Exercise-induced muscle cramps (HP:0003710) | 6.51602212 |
7 | Myokymia (HP:0002411) | 6.44454855 |
8 | Muscle hypertrophy of the lower extremities (HP:0008968) | 5.72559324 |
9 | Focal motor seizures (HP:0011153) | 5.56896170 |
10 | Calf muscle hypertrophy (HP:0008981) | 5.19041664 |
11 | Distal arthrogryposis (HP:0005684) | 4.89038549 |
12 | Myopathic facies (HP:0002058) | 4.79947613 |
13 | EMG: myopathic abnormalities (HP:0003458) | 4.77930784 |
14 | Focal seizures (HP:0007359) | 4.52915597 |
15 | Hyporeflexia of lower limbs (HP:0002600) | 4.26749265 |
16 | Visual hallucinations (HP:0002367) | 4.26078505 |
17 | Abnormality of the calf musculature (HP:0001430) | 4.21547659 |
18 | Ankle clonus (HP:0011448) | 4.21367851 |
19 | Muscle fiber splitting (HP:0003555) | 4.17484251 |
20 | Limb dystonia (HP:0002451) | 4.15637632 |
21 | Myoglobinuria (HP:0002913) | 4.14647882 |
22 | Round ear (HP:0100830) | 4.07493388 |
23 | Rimmed vacuoles (HP:0003805) | 4.07451675 |
24 | Rhabdomyolysis (HP:0003201) | 3.95804388 |
25 | Atonic seizures (HP:0010819) | 3.85708192 |
26 | Supranuclear gaze palsy (HP:0000605) | 3.79641099 |
27 | Subaortic stenosis (HP:0001682) | 3.77184116 |
28 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.77184116 |
29 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.76767655 |
30 | Pheochromocytoma (HP:0002666) | 3.71965775 |
31 | Sudden death (HP:0001699) | 3.71646819 |
32 | Neck muscle weakness (HP:0000467) | 3.58558182 |
33 | Frequent falls (HP:0002359) | 3.57010406 |
34 | Epileptic encephalopathy (HP:0200134) | 3.56021921 |
35 | Progressive cerebellar ataxia (HP:0002073) | 3.50527027 |
36 | Bundle branch block (HP:0011710) | 3.47031641 |
37 | Action tremor (HP:0002345) | 3.45655696 |
38 | Difficulty running (HP:0009046) | 3.45109807 |
39 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.37225771 |
40 | Ulnar deviation of the wrist (HP:0003049) | 3.35180776 |
41 | Absence seizures (HP:0002121) | 3.30144846 |
42 | Neuroendocrine neoplasm (HP:0100634) | 3.26823379 |
43 | Febrile seizures (HP:0002373) | 3.20125437 |
44 | Abnormality of the corticospinal tract (HP:0002492) | 3.16598245 |
45 | Insidious onset (HP:0003587) | 3.16586911 |
46 | Termporal pattern (HP:0011008) | 3.16586911 |
47 | Calcaneovalgus deformity (HP:0001848) | 3.15977740 |
48 | Fetal akinesia sequence (HP:0001989) | 3.14795033 |
49 | Dialeptic seizures (HP:0011146) | 3.14219077 |
50 | Generalized tonic-clonic seizures (HP:0002069) | 3.13123425 |
51 | Spastic gait (HP:0002064) | 3.10176298 |
52 | Muscle stiffness (HP:0003552) | 3.09448034 |
53 | EMG: neuropathic changes (HP:0003445) | 3.06299365 |
54 | Asymmetric septal hypertrophy (HP:0001670) | 2.95467185 |
55 | Neurofibrillary tangles (HP:0002185) | 2.92232593 |
56 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.91477854 |
57 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.91477854 |
58 | Urinary urgency (HP:0000012) | 2.90027674 |
59 | Peripheral hypomyelination (HP:0007182) | 2.87884542 |
60 | Absent phalangeal crease (HP:0006109) | 2.87002532 |
61 | Dysmetria (HP:0001310) | 2.81809858 |
62 | Anxiety (HP:0000739) | 2.81069516 |
63 | Deformed tarsal bones (HP:0008119) | 2.77631800 |
64 | Increased variability in muscle fiber diameter (HP:0003557) | 2.75770990 |
65 | Depression (HP:0000716) | 2.72113103 |
66 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.71799010 |
67 | Truncal ataxia (HP:0002078) | 2.67431707 |
68 | Mutism (HP:0002300) | 2.65647598 |
69 | Abnormal eating behavior (HP:0100738) | 2.65311878 |
70 | Failure to thrive in infancy (HP:0001531) | 2.65196128 |
71 | Cerebral hypomyelination (HP:0006808) | 2.64855282 |
72 | Torticollis (HP:0000473) | 2.63336362 |
73 | Increased connective tissue (HP:0009025) | 2.61952824 |
74 | Distal lower limb muscle weakness (HP:0009053) | 2.61685142 |
75 | Broad-based gait (HP:0002136) | 2.61588554 |
76 | Hypothermia (HP:0002045) | 2.54621287 |
77 | Progressive inability to walk (HP:0002505) | 2.52490820 |
78 | Amblyopia (HP:0000646) | 2.51044201 |
79 | Areflexia of lower limbs (HP:0002522) | 2.47383224 |
80 | Retinal dysplasia (HP:0007973) | 2.47325331 |
81 | Lower limb muscle weakness (HP:0007340) | 2.45427444 |
82 | Scanning speech (HP:0002168) | 2.45036283 |
83 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.44987169 |
84 | Malignant hyperthermia (HP:0002047) | 2.43169976 |
85 | Postural instability (HP:0002172) | 2.41246986 |
86 | Polyphagia (HP:0002591) | 2.40459305 |
87 | Cerebral inclusion bodies (HP:0100314) | 2.39820079 |
88 | Generalized muscle weakness (HP:0003324) | 2.38573264 |
89 | Onion bulb formation (HP:0003383) | 2.35108889 |
90 | Abnormal finger flexion creases (HP:0006143) | 2.32743182 |
91 | Focal dystonia (HP:0004373) | 2.32223940 |
92 | Dilated cardiomyopathy (HP:0001644) | 2.29344047 |
93 | Gait imbalance (HP:0002141) | 2.27591983 |
94 | Craniofacial dystonia (HP:0012179) | 2.27470386 |
95 | Heart block (HP:0012722) | 2.27386894 |
96 | Clonus (HP:0002169) | 2.26849635 |
97 | Dysdiadochokinesis (HP:0002075) | 2.26638900 |
98 | Specific learning disability (HP:0001328) | 2.26322719 |
99 | Sensory axonal neuropathy (HP:0003390) | 2.24956317 |
100 | Poor eye contact (HP:0000817) | 2.24938749 |
101 | Ulnar claw (HP:0001178) | 2.24428249 |
102 | Gaze-evoked nystagmus (HP:0000640) | 2.22652676 |
103 | Scapular winging (HP:0003691) | 2.20534132 |
104 | Impaired pain sensation (HP:0007328) | 2.18116479 |
105 | Abnormality of pain sensation (HP:0010832) | 2.18116479 |
106 | Agitation (HP:0000713) | 2.17693726 |
107 | Abnormality of the foot musculature (HP:0001436) | 2.17566128 |
108 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.15455900 |
109 | Myotonia (HP:0002486) | 2.15227920 |
110 | Ventricular tachycardia (HP:0004756) | 2.13911544 |
111 | Epileptiform EEG discharges (HP:0011182) | 2.13633414 |
112 | Abnormal hair whorl (HP:0010721) | 2.13552086 |
113 | EEG with generalized epileptiform discharges (HP:0011198) | 2.13317267 |
114 | Intention tremor (HP:0002080) | 2.12230281 |
115 | Weak cry (HP:0001612) | 2.10910402 |
116 | Limb-girdle muscle atrophy (HP:0003797) | 2.10091872 |
117 | Distal lower limb amyotrophy (HP:0008944) | 2.07336791 |
118 | Hypoventilation (HP:0002791) | 2.07027152 |
119 | Psychosis (HP:0000709) | 2.06702049 |
120 | Hyperventilation (HP:0002883) | 2.04263202 |
121 | Abnormal atrioventricular conduction (HP:0005150) | 2.03259849 |
122 | Hypsarrhythmia (HP:0002521) | 2.02322856 |
123 | Delusions (HP:0000746) | 2.02288270 |
124 | Lower limb amyotrophy (HP:0007210) | 2.01512818 |
125 | Impaired social interactions (HP:0000735) | 2.00838155 |
126 | Abnormal social behavior (HP:0012433) | 2.00838155 |
127 | Esotropia (HP:0000565) | 2.00507442 |
128 | Hypoplasia of the brainstem (HP:0002365) | 2.00426648 |
129 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 2.00426648 |
130 | Gowers sign (HP:0003391) | 2.00078616 |
131 | Excessive salivation (HP:0003781) | 1.98440116 |
132 | Drooling (HP:0002307) | 1.98440116 |
133 | Bradykinesia (HP:0002067) | 1.97900752 |
134 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.97432929 |
135 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.97326505 |
136 | Rigidity (HP:0002063) | 1.96997511 |
137 | Poor speech (HP:0002465) | 1.96931517 |
138 | Bulbar palsy (HP:0001283) | 1.96730069 |
139 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.95393334 |
140 | Hyperkalemia (HP:0002153) | 1.94783830 |
141 | Ventricular arrhythmia (HP:0004308) | 1.94036058 |
142 | Poor suck (HP:0002033) | 1.92249811 |
143 | Postural tremor (HP:0002174) | 1.91501999 |
144 | Lipoatrophy (HP:0100578) | 1.91353979 |
145 | Genital tract atresia (HP:0001827) | 1.91149137 |
146 | Megalencephaly (HP:0001355) | 1.90137299 |
147 | Ventricular fibrillation (HP:0001663) | 1.89642806 |
148 | Vaginal atresia (HP:0000148) | 1.89256569 |
149 | Akinesia (HP:0002304) | 1.87906070 |
150 | Congenital primary aphakia (HP:0007707) | 1.87393932 |
151 | Foot dorsiflexor weakness (HP:0009027) | 1.85988111 |
152 | Difficulty climbing stairs (HP:0003551) | 1.85737109 |
153 | Muscular hypotonia of the trunk (HP:0008936) | 1.85461382 |
154 | Hip contracture (HP:0003273) | 1.85314444 |
155 | Proximal amyotrophy (HP:0007126) | 1.85065934 |
156 | Menstrual irregularities (HP:0000858) | 1.84742240 |
157 | Fatigable weakness (HP:0003473) | 1.84558716 |
158 | Abnormality of the neuromuscular junction (HP:0003398) | 1.84558716 |
159 | CNS hypomyelination (HP:0003429) | 1.83771388 |
160 | Hyperthyroidism (HP:0000836) | 1.83532948 |
161 | Hammertoe (HP:0001765) | 1.83381642 |
162 | Slender build (HP:0001533) | 1.83044155 |
163 | Waddling gait (HP:0002515) | 1.82790438 |
164 | Hemiparesis (HP:0001269) | 1.82568935 |
165 | Muscular dystrophy (HP:0003560) | 1.81871734 |
166 | Left ventricular hypertrophy (HP:0001712) | 1.81796123 |
167 | Atrial fibrillation (HP:0005110) | 1.81195623 |
168 | Syncope (HP:0001279) | 1.80801789 |
169 | Bowel incontinence (HP:0002607) | 1.80446227 |
170 | Abnormal EKG (HP:0003115) | 1.80304342 |
171 | Oligomenorrhea (HP:0000876) | 1.79757149 |
172 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.78547884 |
173 | Prolonged QT interval (HP:0001657) | 1.78414472 |
174 | Primary atrial arrhythmia (HP:0001692) | 1.78185965 |
175 | Nonprogressive disorder (HP:0003680) | 1.72749433 |
176 | Supraventricular tachycardia (HP:0004755) | 1.70811116 |
177 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.64726763 |
178 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.64726763 |
179 | Supraventricular arrhythmia (HP:0005115) | 1.64271102 |
180 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.64067689 |
181 | Exercise intolerance (HP:0003546) | 1.62817981 |
182 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.61744042 |
183 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.61279981 |
Rank | Gene Set | Z-score |
---|---|---|
1 | OBSCN | 7.65036906 |
2 | TTN | 4.09543371 |
3 | NTRK3 | 3.44640651 |
4 | MAP3K9 | 3.14940439 |
5 | MARK1 | 3.00130358 |
6 | CASK | 2.59690113 |
7 | NTRK1 | 2.55396851 |
8 | MINK1 | 2.53000878 |
9 | MAP3K4 | 2.42235489 |
10 | EPHA4 | 2.38003500 |
11 | PAK6 | 2.16218317 |
12 | KSR2 | 2.12266866 |
13 | MAP2K7 | 2.08678912 |
14 | MAP3K12 | 2.06564146 |
15 | GRK5 | 1.93724361 |
16 | MAPK12 | 1.89973886 |
17 | UHMK1 | 1.89692283 |
18 | NTRK2 | 1.88957565 |
19 | DAPK2 | 1.80526989 |
20 | MAPK13 | 1.75015774 |
21 | STK39 | 1.68508991 |
22 | PIK3CG | 1.65613082 |
23 | LIMK1 | 1.65454737 |
24 | OXSR1 | 1.63527539 |
25 | PHKG2 | 1.61892225 |
26 | PHKG1 | 1.61892225 |
27 | PNCK | 1.61202995 |
28 | PRKD3 | 1.59368091 |
29 | MAP2K4 | 1.55965349 |
30 | SGK494 | 1.55537571 |
31 | SGK223 | 1.55537571 |
32 | PRPF4B | 1.55312149 |
33 | ARAF | 1.55118369 |
34 | CDK19 | 1.54815380 |
35 | CDK5 | 1.48840631 |
36 | MAP3K2 | 1.38354862 |
37 | PINK1 | 1.27099948 |
38 | MAPKAPK5 | 1.26303232 |
39 | TNIK | 1.19980308 |
40 | CSNK1G2 | 1.18774494 |
41 | RIPK4 | 1.16821794 |
42 | CDK14 | 1.12505149 |
43 | BCR | 1.11163416 |
44 | DMPK | 1.08989942 |
45 | CSNK1G3 | 1.08063558 |
46 | CAMK2B | 1.07902222 |
47 | CAMK2A | 1.07255264 |
48 | MAP3K7 | 1.07208784 |
49 | KSR1 | 1.06542361 |
50 | CAMKK1 | 1.05249917 |
51 | CAMKK2 | 1.03031685 |
52 | CDK18 | 1.01761523 |
53 | PKN1 | 1.01285755 |
54 | PLK2 | 0.99314334 |
55 | PRKCG | 0.99183132 |
56 | CDK15 | 0.97927568 |
57 | DYRK1B | 0.97108606 |
58 | RET | 0.93758608 |
59 | NME1 | 0.93068728 |
60 | PAK3 | 0.89080746 |
61 | DYRK2 | 0.88841669 |
62 | MAP2K6 | 0.85811245 |
63 | CAMK4 | 0.85589144 |
64 | CDK11A | 0.85043714 |
65 | WNK4 | 0.84612014 |
66 | FES | 0.83719708 |
67 | CAMK2D | 0.83508331 |
68 | PRKAA1 | 0.82682198 |
69 | TYRO3 | 0.81783264 |
70 | CAMK2G | 0.80360614 |
71 | WNK1 | 0.78973182 |
72 | SGK3 | 0.78256002 |
73 | PRKCE | 0.77332028 |
74 | ADRBK2 | 0.73964622 |
75 | DAPK1 | 0.71628354 |
76 | LMTK2 | 0.70363704 |
77 | MUSK | 0.69764562 |
78 | DYRK1A | 0.69457938 |
79 | SIK3 | 0.69146770 |
80 | SIK2 | 0.68726560 |
81 | PRKCH | 0.67695806 |
82 | CSNK1A1L | 0.66825916 |
83 | WNK3 | 0.66768110 |
84 | MAP3K1 | 0.65123327 |
85 | GRK7 | 0.64921748 |
86 | MARK2 | 0.64247918 |
87 | ROCK2 | 0.64013216 |
88 | NEK6 | 0.62620791 |
89 | CSNK1G1 | 0.61010318 |
90 | STK11 | 0.60778342 |
91 | PRKG1 | 0.60152852 |
92 | MAP2K1 | 0.58612332 |
93 | MAPKAPK3 | 0.57900333 |
94 | MAP3K13 | 0.57805803 |
95 | ERBB3 | 0.57465101 |
96 | TNK2 | 0.56676416 |
97 | CAMK1 | 0.56161405 |
98 | STK38 | 0.56095250 |
99 | PRKCZ | 0.56043785 |
100 | CCNB1 | 0.55104066 |
101 | ADRBK1 | 0.54670587 |
102 | FRK | 0.54496684 |
103 | LATS2 | 0.54001081 |
104 | SGK2 | 0.53926852 |
105 | PRKAA2 | 0.53462727 |
106 | BCKDK | 0.51743857 |
107 | ROCK1 | 0.51739909 |
108 | DAPK3 | 0.51533638 |
109 | RPS6KA2 | 0.50306971 |
110 | PDPK1 | 0.49096000 |
111 | FER | 0.48342450 |
112 | FGFR2 | 0.47991050 |
113 | BRAF | 0.46799910 |
114 | SGK1 | 0.46532251 |
115 | MOS | 0.46339711 |
116 | MAPK4 | 0.44766617 |
117 | TRPM7 | 0.44211099 |
118 | PRKACA | 0.42870573 |
119 | MAP2K3 | 0.42223793 |
120 | FGR | 0.41565730 |
121 | AKT2 | 0.41435213 |
122 | FYN | 0.40253806 |
123 | MAPK10 | 0.40159963 |
124 | MAP3K11 | 0.39988570 |
125 | RPS6KA3 | 0.39971596 |
126 | MAPK7 | 0.38899040 |
127 | RIPK1 | 0.38886406 |
128 | PIK3CA | 0.38333994 |
129 | RAF1 | 0.35777825 |
130 | PRKACB | 0.34180378 |
131 | RPS6KB1 | 0.28559884 |
132 | PRKACG | 0.25740762 |
133 | PDK1 | 0.25569387 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.71682932 |
2 | Nicotine addiction_Homo sapiens_hsa05033 | 3.22986125 |
3 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 2.80564718 |
4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.72722537 |
5 | GABAergic synapse_Homo sapiens_hsa04727 | 2.66743347 |
6 | Olfactory transduction_Homo sapiens_hsa04740 | 2.46383182 |
7 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.41178622 |
8 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.36970222 |
9 | Morphine addiction_Homo sapiens_hsa05032 | 2.30145030 |
10 | Circadian entrainment_Homo sapiens_hsa04713 | 2.25054913 |
11 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.23141479 |
12 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.14710550 |
13 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 2.13484295 |
14 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.11387883 |
15 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.07191542 |
16 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.06977140 |
17 | Insulin secretion_Homo sapiens_hsa04911 | 2.04580961 |
18 | Cocaine addiction_Homo sapiens_hsa05030 | 1.98215455 |
19 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.91750882 |
20 | Long-term potentiation_Homo sapiens_hsa04720 | 1.91586034 |
21 | Taste transduction_Homo sapiens_hsa04742 | 1.84568287 |
22 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.81167898 |
23 | Salivary secretion_Homo sapiens_hsa04970 | 1.79206915 |
24 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.67958961 |
25 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.60919990 |
26 | Long-term depression_Homo sapiens_hsa04730 | 1.58639485 |
27 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.58361264 |
28 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.57263690 |
29 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.55257399 |
30 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.53963705 |
31 | Parkinsons disease_Homo sapiens_hsa05012 | 1.51841584 |
32 | Phototransduction_Homo sapiens_hsa04744 | 1.49769659 |
33 | Renin secretion_Homo sapiens_hsa04924 | 1.47171495 |
34 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.44022065 |
35 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.43996844 |
36 | Gap junction_Homo sapiens_hsa04540 | 1.39627634 |
37 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.38321190 |
38 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.33010097 |
39 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.32993443 |
40 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.31410607 |
41 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.29134327 |
42 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.28989995 |
43 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.24201850 |
44 | Alzheimers disease_Homo sapiens_hsa05010 | 1.23962645 |
45 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.20181106 |
46 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.18856811 |
47 | Axon guidance_Homo sapiens_hsa04360 | 1.16023690 |
48 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.14827284 |
49 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.04924433 |
50 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.02554684 |
51 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.99990547 |
52 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.97987483 |
53 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.97530895 |
54 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.96389989 |
55 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.95230464 |
56 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.93647011 |
57 | Carbon metabolism_Homo sapiens_hsa01200 | 0.92631157 |
58 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.91585619 |
59 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.90454789 |
60 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.88879295 |
61 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.88134722 |
62 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.85696896 |
63 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.84408438 |
64 | Huntingtons disease_Homo sapiens_hsa05016 | 0.81944030 |
65 | Melanogenesis_Homo sapiens_hsa04916 | 0.79399181 |
66 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.79126131 |
67 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.78802946 |
68 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.76565984 |
69 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.71678886 |
70 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.71167128 |
71 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.70760339 |
72 | Insulin resistance_Homo sapiens_hsa04931 | 0.69570654 |
73 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.66740452 |
74 | Glioma_Homo sapiens_hsa05214 | 0.66621973 |
75 | Alcoholism_Homo sapiens_hsa05034 | 0.66313299 |
76 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.66113565 |
77 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.64035075 |
78 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.63432101 |
79 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.63292530 |
80 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.62745369 |
81 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.61051438 |
82 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.59698618 |
83 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.59325937 |
84 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.59102428 |
85 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.58464956 |
86 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.57568682 |
87 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.56766549 |
88 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.56598023 |
89 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.56281612 |
90 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.56095155 |
91 | Prion diseases_Homo sapiens_hsa05020 | 0.56070574 |
92 | Tight junction_Homo sapiens_hsa04530 | 0.55022168 |
93 | Endocytosis_Homo sapiens_hsa04144 | 0.54827947 |
94 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.54296397 |
95 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.54022813 |
96 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.53593760 |
97 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.51635316 |
98 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.50848567 |
99 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.48200802 |
100 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.46920668 |
101 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.46462092 |
102 | Phagosome_Homo sapiens_hsa04145 | 0.45556940 |
103 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.45286594 |
104 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.44825153 |
105 | Circadian rhythm_Homo sapiens_hsa04710 | 0.42533361 |
106 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.41274672 |
107 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.40790224 |
108 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.40395617 |
109 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.39457151 |
110 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.39362415 |
111 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.39061236 |
112 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.38411583 |
113 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.37673637 |
114 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.37585755 |
115 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.36224821 |
116 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.36089959 |
117 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.35283955 |
118 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.34748830 |
119 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.34408817 |
120 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.34393097 |
121 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.32761191 |
122 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.32328775 |
123 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.32089657 |
124 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.31806559 |
125 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.31184802 |
126 | Bile secretion_Homo sapiens_hsa04976 | 0.30661804 |
127 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.29553475 |
128 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.28781446 |
129 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.27832631 |
130 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.27667942 |
131 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.27420072 |